ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153353; 2) Community: the network communities that were significantly associated with the response to NSC 153353; 3) Molecule: the relationships between components within communities and NSC 153353; 4) MDR: the compounds that were significantly associated with the NSC 153353.

NSC Compound Enrichment Correlation
NSC 709969 Null 0.0187206825450445 -0.0071912852
NSC 711102 Null 0.0187206825450445 -0.036998669
NSC 711806 Null 0.0187206825450445 0.11517431
NSC 715229 Null 0.0187206825450445 -0.040484979
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0187206825450445 -0.079444683
NSC 736116 6-(3-Amonopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0187206825450445 0.2021353
NSC 743862 Null 0.0187206825450445 0.17730953
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0187206825450445 0.19880538
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0187206825450445 0.13147925
NSC 758664 Sirolimus [USAN] 0.0187206825450445 0.095032575
Total:92  Current:47    [First] [Prev] [Next] [Last]